| By Quadro Engineering |
| Monday, 28 December 2009 |
 |
According to leading containment isolator manufacturers, it has been estimated that up to 50% of new pharmaceutical products are now being set by the pharmaceutical industry with Operator Exposure
|
|
Limits (OEL's) at =10µg/m3.
A leading European Pharmaceutical company needed to complete various clinical trials with batch sizes of highly dusty materials weighing between 1 - 20kg through a U5 Comil®.
The STEL (Short Term Exposure Limit) of the worst case APIs (Active Pharmaceutical Ingredients) that the customer is planning on milling is
|
|
|
40µg/m3.
The U5 Comil® is housed within an isolator and the mill's spindle had to provide containment of API blends to 5µg/m3 when processing.
In testing developed by the customer and conducted by the isolator manufacturer, the U5 Comil® was subjected to a pressure of 150 Pa for one minute.
The maximum allowable pressure drop in the plastic simulation bag after one minute was 8 Pa.
The isolator company tested the U5 head as per the testing protocol and the U5 Comil® achieved a 1 Pa pressure drop over a one minute |
|
interval, exceeding the requirements by a large margin.
Quadro® Comils® are designed to the strictest cGMP standards and have proven themselves over the years to provide maximum containment capabilities, making the Comil® the mill of choice for many isolator manufacturers and end users alike.
Want to read more?
Monash University Researchers Seek To Improve Inhaled Drug Formulations
FrieslandCampina Domo Name Change Process Aims To Ensure A Seamless Transition For American Customers
Patheon And Lonza Agree To Extend Exclusivity Period
|
|
|
